Detalles de la búsqueda
1.
Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multi-center nation-wide cohort.
Haematologica
; 107(2): 467-477, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33406815
2.
Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection.
Am J Hematol
; 97(2): E75-E78, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34861054
3.
Switching from dispersible to film coated tablet formulation of deferasirox improves hemoglobin levels and transfusional interval in patients with transfusion-dependent-thalassemia.
Br J Haematol
; 189(2): e60-e63, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32119115
4.
Prospective changes of pancreatic iron in patients with thalassemia major and association with chelation therapy.
Blood Adv
; 7(10): 2237-2240, 2023 05 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36332057
Resultados
1 -
4
de 4
1
Próxima >
>>